Trial Profile
An investigator sponsored trial of ADXS-PSA in patients with earlier stage prostate cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2023
Price :
$35
*
At a glance
- Drugs ADXS 31142 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Jan 2023 According to an Ayala Pharmaceuticals media release, Advaxis merged with Ayala Pharmaceuticals to form Ayala Pharmaceuticals.
- 21 Jun 2017 New trial record
- 13 Jun 2017 According to an Advaxis media release, plans related to this trial presented at annual Investor & Analyst Day.